carbamazepine has been researched along with Colorectal Neoplasms in 3 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study we evaluated the efficacy and safety of carbamazepine for prevention of oxaliplatin-associated neuropathy in patients with advanced colorectal cancer." | 9.12 | Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. ( Adelsberger, H; Bredenkamp, R; Eckel, F; Erdmann, J; Kullmann, F; Lersch, C; Mayr, M; Obermeier, F; Quasthoff, S; Schmelz, R; Schmid, RM; Stock, K; von Delius, S; Wagenpfeil, S, 2007) |
| " In this study we evaluated the efficacy and safety of carbamazepine for prevention of oxaliplatin-associated neuropathy in patients with advanced colorectal cancer." | 5.12 | Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. ( Adelsberger, H; Bredenkamp, R; Eckel, F; Erdmann, J; Kullmann, F; Lersch, C; Mayr, M; Obermeier, F; Quasthoff, S; Schmelz, R; Schmid, RM; Stock, K; von Delius, S; Wagenpfeil, S, 2007) |
| "Carbamazepine levels were 4." | 1.31 | [Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study]. ( Adelsberger, H; Eckel, F; Erdmann, J; Lersch, C; Quasthoff, S; Schmelz, R, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lersch, C | 3 |
| Schmelz, R | 3 |
| Eckel, F | 3 |
| Erdmann, J | 3 |
| Mayr, M | 2 |
| Schulte-Frohlinde, E | 1 |
| Quasthoff, S | 3 |
| Grosskreutz, J | 1 |
| Adelsberger, H | 3 |
| von Delius, S | 1 |
| Wagenpfeil, S | 1 |
| Stock, K | 1 |
| Kullmann, F | 1 |
| Obermeier, F | 1 |
| Bredenkamp, R | 1 |
| Schmid, RM | 1 |
1 trial available for carbamazepine and Colorectal Neoplasms
| Article | Year |
|---|---|
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Antineoplastic Agents; Carbamazepine; Colorectal Ne | 2007 |
2 other studies available for carbamazepine and Colorectal Neoplasms
| Article | Year |
|---|---|
Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
Topics: Animals; Antineoplastic Agents; Carbamazepine; Colorectal Neoplasms; Humans; In Vitro Techniques; Ne | 2002 |
[Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2002 |